Bard Loses Appeal, Set to Pay $2 Million in Mesh Verdict
by Ty Armstrong
Last Updated on June 26, 2017
C.R. Bard, Inc. lost its appeal of a jury’s $2 million verdict in Fourth Circuit appellate court on Thursday. The court found that the medical device manufacturer was, in fact, responsible for the injuries the plaintiff suffered after she was implanted with the company’s transvaginal mesh device. In the appeal, Bard claimed that the district court wrongly excluded evidence regarding the FDA’s approval of its product. The court decided that the approval of the product did not adequately represent its safety, only how well it matched something already on the market.
Depo-Provera Lawsuits
Anyone who received Depo-Provera or Depo-Provera SubQ injections and has been diagnosed with meningioma, a type of brain tumor, may be able to take legal action.
Read more:Depo-Provera Lawsuit
How Do I Join a Class Action Lawsuit?
Did you know there's usually nothing you need to do to join, sign up for, or add your name to new class action lawsuits when they're initially filed?
Read more here: How Do I Join a Class Action Lawsuit?
Stay Current
Sign Up For
Our Newsletter
New cases and investigations, settlement deadlines, and news straight to your inbox.
Before commenting, please review our comment policy.